Viewing Study NCT06963320


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-01-07 @ 2:01 PM
Study NCT ID: NCT06963320
Status: RECRUITING
Last Update Posted: 2025-05-09
First Post: 2025-04-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
Sponsor: Livzon Pharmaceutical Group Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-01-20
Start Date Type: ACTUAL
Primary Completion Date: 2025-06-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-07-30
Completion Date Type: ESTIMATED
First Submit Date: 2025-04-30
First Submit QC Date: None
Study First Post Date: 2025-05-09
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-30
Last Update Post Date: 2025-05-09
Last Update Post Date Type: ACTUAL